Dr. Bible is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 605-720-7171- Is this information wrong?
Education & Training
Mayo Clinic College of MedicinePost-Doctoral Fellowship, Cancer Pharmacology Research, 1995 - 1997- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1992 - 1995
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
University of Illinois at Urbana-ChampaignPhD, Chemistry, 1983 - 1989
University of Illinois College of MedicineClass of 1983
Washington University in St. LouisB.S./A.B., Chemistry&Anthropology, Phi Beta Kappa, 1976 - 1979
Certifications & Licensure
MN State Medical License 1990 - 2024
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors Start of enrollment: 1998 Dec 01
- Combination Chemotherapy in Treating Patients With Advanced Cancer Start of enrollment: 2001 May 01
- Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer Start of enrollment: 2008 Feb 22
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsRadiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase ...Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein, Christine H Chung, Nadeem Riaz, G Brandon Gunn, Robert L Foote, Sue S Yom, Stuart J Wong, ...> ;The Lancet. Oncology. 2023 Feb 1
- 30 citationsAmerican Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining...David C Shonka Jr, Alan Ho, Ashish V Chintakuntlawar, Jessica L Geiger, Jong C Park, Nagashree Seetharamu, Sina Jasim, Amr H Abdelhamid Ahmed, Keith C Bible, Marcia S ...> ;Head & Neck. 2022 Jun 1
- 3 citationsLenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas.Lauren Hassan Nelson, Harry Fuentes-Bayne, Jun Yin, Erik Asmus, Mabel Ryder, John C Morris, Crystal R Hilger, Keith C Bible, Ashish V Chintakuntlawar, Sarika N Rao> ;Journal of the Endocrine Society. 2022 May 1
- Join now to see all
Press Mentions
Novel Treatments, Effective Combinations Still Needed in Thyroid CancerMay 26th, 2016
Study to Treat Deadly Form of Thyroid Cancer Shows PromiseApril 18th, 2013
Grant Support
- Flavopiridol Reverses Platinum Resistance In Ovarian CancerNational Cancer Institute2009–2011
- Chaetocin As A Potential Therapy For Multiple MyelomaNational Cancer Institute2008–2011
- Flavopiridol Targets Transcription Factor/Dna ComplexesNational Cancer Institute2004–2006
- Flavopiridol As A Potential Therapy In Multiple MyelomaNational Cancer Institute2004–2005
- Flavopiridol Targets Transcription Factor/Dna ComplexesNational Cancer Institute2003
- Flavopiridol As A Potential Therapy In Multiple MyelomaNational Cancer Institute2003
- Phase I: Flavopiridol And Cisplatin In Advanced CancerNational Center For Research Resources2000–2002
Professional Memberships
- Member
- Member, Anaplastic Thyroid Cancer Task Force and Guidelines Committee; Member, Thyroid Nodules and Differentiated Thyroid Cancer Task Force and Guidelines Committee; Member, Ethics Advisory Committee
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
